Clinical Trial Update: Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study) [Phase 3]

View source ↗

Summary

The OPERA-T Phase 3 trial evaluating Opelconazole (PC945) in combination with other antifungals for refractory invasive pulmonary aspergillosis has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pulmonary Aspergillosis

Drugs mentioned

• Opelconazole (PC945) (opelconazole)

Snippet

Sponsor: Pulmocide Ltd | Conditions: Refractory IPA | Phase 3 | Status: TERMINATED